Literature DB >> 23463815

Dissecting the molecular relationship among various cardiogenic progenitor cells.

Devaveena Dey1, Leng Han, Michael Bauer, Fumihiro Sanada, Angelos Oikonomopoulos, Toru Hosoda, Kazumasa Unno, Patricia De Almeida, Annarosa Leri, Joseph C Wu.   

Abstract

RATIONALE: Multiple progenitors derived from the heart and bone marrow (BM) have been used for cardiac repair. Despite this, not much is known about the molecular identity and relationship among these progenitors. To develop a robust stem cell therapy for the heart, it is critical to understand the molecular identity of the multiple cardiogenic progenitor cells.
OBJECTIVE: This study is the first report of high-throughput transcriptional profiling of cardiogenic progenitor cells carried out on an identical platform. METHOD AND
RESULTS: Microarray-based transcriptional profiling was carried out for 3 cardiac (ckit(+), Sca1(+), and side population) and 2 BM (ckit(+) and mesenchymal stem cell) progenitors, obtained from age- and sex-matched wild-type C57BL/6 mice. Analysis indicated that cardiac-derived ckit(+) population was very distinct from Sca1(+) and side population cells in the downregulation of genes encoding for cell-cell and cell-matrix adhesion proteins, and in the upregulation of developmental genes. Significant enrichment of transcripts involved in DNA replication and repair was observed in BM-derived progenitors. The BM ckit(+) cells seemed to have the least correlation with the other progenitors, with enrichment of immature neutrophil-specific molecules.
CONCLUSIONS: Our study indicates that cardiac ckit(+) cells represent the most primitive population in the rodent heart. Primitive cells of cardiac versus BM origin differ significantly with respect to stemness and cardiac lineage-specific genes, and molecules involved in DNA replication and repair. The detailed molecular profile of progenitors reported here will serve as a useful reference to determine the molecular identity of progenitors used in future preclinical and clinical studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23463815      PMCID: PMC3657513          DOI: 10.1161/CIRCRESAHA.112.300779

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  42 in total

Review 1.  The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells.

Authors:  A Wessels; J M Pérez-Pomares
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2004-01

2.  Immunohistochemical and flow cytometric analysis of long-term label-retaining cells in the adult heart.

Authors:  Andrea Meinhardt; Albert Spicher; Marc-Estienne Roehrich; Ingmar Glauche; Pierre Vogt; Giuseppe Vassalli
Journal:  Stem Cells Dev       Date:  2010-09-14       Impact factor: 3.272

3.  Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Authors:  Gerd P Meyer; Kai C Wollert; Joachim Lotz; Jan Steffens; Peter Lippolt; Stephanie Fichtner; Hartmut Hecker; Arnd Schaefer; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Circulation       Date:  2006-03-06       Impact factor: 29.690

4.  Nonmuscle myosin II isoform and domain specificity during early mouse development.

Authors:  Aibing Wang; Xuefei Ma; Mary Anne Conti; Chengyu Liu; Sachiyo Kawamoto; Robert S Adelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

5.  The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors.

Authors:  Christian W Scharenberg; Michael A Harkey; Beverly Torok-Storb
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

6.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

7.  Chimerism of the transplanted heart.

Authors:  Federico Quaini; Konrad Urbanek; Antonio P Beltrami; Nicoletta Finato; Carlo A Beltrami; Bernardo Nadal-Ginard; Jan Kajstura; Annarosa Leri; Piero Anversa
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

8.  Regenerating functional myocardium: improved performance after skeletal myoblast transplantation.

Authors:  D A Taylor; B Z Atkins; P Hungspreugs; T R Jones; M C Reedy; K A Hutcheson; D D Glower; W E Kraus
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

9.  Mesenchymal stem cells avoid allogeneic rejection.

Authors:  Jennifer M Ryan; Frank P Barry; J Mary Murphy; Bernard P Mahon
Journal:  J Inflamm (Lond)       Date:  2005-07-26       Impact factor: 4.981

10.  Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo.

Authors:  Tomomi Oyama; Toshio Nagai; Hiroshi Wada; Atsuhiko Thomas Naito; Katsuhisa Matsuura; Koji Iwanaga; Toshinao Takahashi; Motohiro Goto; Yoko Mikami; Noritaka Yasuda; Hiroshi Akazawa; Akiyoshi Uezumi; Shin'ichi Takeda; Issei Komuro
Journal:  J Cell Biol       Date:  2007-01-29       Impact factor: 10.539

View more
  49 in total

1.  Comparative Efficacy of Intracoronary Allogeneic Mesenchymal Stem Cells and Cardiosphere-Derived Cells in Swine with Hibernating Myocardium.

Authors:  Brian R Weil; Gen Suzuki; Merced M Leiker; James A Fallavollita; John M Canty
Journal:  Circ Res       Date:  2015-08-13       Impact factor: 17.367

Review 2.  Molecular basis of functional myogenic specification of Bona Fide multipotent adult cardiac stem cells.

Authors:  Eleonora Cianflone; Iolanda Aquila; Mariangela Scalise; Pina Marotta; Michele Torella; Bernardo Nadal-Ginard; Daniele Torella
Journal:  Cell Cycle       Date:  2018-06-25       Impact factor: 4.534

3.  Prion Protein and Stage Specific Embryo Antigen 1 as Selection Markers to Enrich the Fraction of Murine Embryonic Stem Cell-Derived Cardiomyocytes.

Authors:  Nobuhito Ikeda; Yuji Nakayama; Natsumi Nakazawa; Akio Yoshida; Haruaki Ninomiya; Yasuaki Shirayoshi
Journal:  Yonago Acta Med       Date:  2016-06-29       Impact factor: 1.641

Review 4.  Developmental origin and lineage plasticity of endogenous cardiac stem cells.

Authors:  Maria Paola Santini; Elvira Forte; Richard P Harvey; Jason C Kovacic
Journal:  Development       Date:  2016-04-15       Impact factor: 6.868

Review 5.  Making it stick: chasing the optimal stem cells for cardiac regeneration.

Authors:  Pearl Quijada; Mark A Sussman
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-11

6.  Abcg2-expressing side population cells contribute to cardiomyocyte renewal through fusion.

Authors:  Amritha Yellamilli; Yi Ren; Ron T McElmurry; Jonathan P Lambert; Polina Gross; Sadia Mohsin; Steven R Houser; John W Elrod; Jakub Tolar; Daniel J Garry; Jop H van Berlo
Journal:  FASEB J       Date:  2020-02-25       Impact factor: 5.191

Review 7.  Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discovery.

Authors:  Katherine A Campbell; Andre Terzic; Timothy J Nelson
Journal:  Regen Med       Date:  2015-10-06       Impact factor: 3.806

8.  Pediatric End-Stage Failing Hearts Demonstrate Increased Cardiac Stem Cells.

Authors:  Brody Wehman; Sudhish Sharma; Rachana Mishra; Yin Guo; Evan J Colletti; Zachary N Kon; Srinivasa Raju Datla; Osama T Siddiqui; Keerti Balachandran; Sunjay Kaushal
Journal:  Ann Thorac Surg       Date:  2015-06-30       Impact factor: 4.330

9.  Cellular and molecular characterization of human cardiac stem cells reveals key features essential for their function and safety.

Authors:  Sadaf Vahdat; Seyed Ahmad Mousavi; Gholamreza Omrani; Maziar Gholampour; Fattah Sotoodehnejadnematalahi; Zaniar Ghazizadeh; Javad Gharechahi; Hossein Baharvand; Ghasem Hosseini Salekdeh; Nasser Aghdami
Journal:  Stem Cells Dev       Date:  2015-06-15       Impact factor: 3.272

Review 10.  Myocyte renewal and therapeutic myocardial regeneration using various progenitor cells.

Authors:  Emiko Hayashi; Toru Hosoda
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.